Home Cart Sign in  
Chemical Structure| 2407782-01-6 Chemical Structure| 2407782-01-6

Structure of LDC7559
CAS No.: 2407782-01-6

Chemical Structure| 2407782-01-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

LDC7559 is an inhibitor of gasdermin D (GSDMD) that functions by inhibiting the later stages of neutrophil extracellular trap (NET) formation.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of LDC7559

CAS No. :2407782-01-6
Formula : C20H19N3O3
M.W : 349.38
SMILES Code : CC(NC1=CC=C2CN3C(COC2=C1)=CC(C4=CC=CC=C4OC)=N3)=O
MDL No. :MFCD31813902

Safety of LDC7559

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
THP-1 cells 5 μM 1 hour did not affect GSDMD-dependent cell death Cell. 2021 Aug 19;184(17):4480-4494. e15
neutrophils 10 μM 3 hours inhibited NETosis Cell. 2021 Aug 19;184(17):4480-4494. e15
Primary microglia 5, 25, or 50 µM LDC7559 inhibited microglial activation and inflammatory response. Front Immunol. 2023 Mar 29;14:1117310
Primary cortical neurons 5, 25, or 50 µM LDC7559 dose-dependently inhibited proinflammatory cytokines release and improved cell viability. Front Immunol. 2023 Mar 29;14:1117310

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice 4T1 breast cancer model Oral 20 mg/kg Daily administration for two weeks To evaluate the effect of LDC7559 on breast cancer lung metastasis. Results showed that LDC7559 significantly reduced the number and size of lung metastatic nodules and decreased the expression levels of pro-inflammatory cytokines IL-1β, IL-18, and HMGB1. Cell Death Discov. 2025 May 6;11(1):219
Sprague-Dawley rats Subarachnoid hemorrhage (SAH) model Intraperitoneal injection 10, 20, or 30 mg/kg Once daily LDC7559 significantly inhibited microglial activation and neuronal pyroptosis, improving neurological function. Front Immunol. 2023 Mar 29;14:1117310

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.86mL

0.57mL

0.29mL

14.31mL

2.86mL

1.43mL

28.62mL

5.72mL

2.86mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories